Cargando…
Metformin Treatment in Hyperglycemic Critically Ill Patients: Another Challenge on the Control of Adverse Outcomes
New-onset hyperglycemia in patients admitted to intensive care units increases the risk of morbidity and mortality. Insulin resistance is frequently seen in the treatment of stress-induced hyperglycemia. Metformin, an oral anti-hyperglycemic agent, may introduce a new treatment protocol in criticall...
Autores principales: | Panahi, Yunes, Mojtahedzadeh, Mojtaba, Zekeri, Nuria, Beiraghdar, Fatemeh, Khajavi, Mohammad-Reza, Ahmadi, Arezo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813075/ https://www.ncbi.nlm.nih.gov/pubmed/24250430 |
Ejemplares similares
-
Microalbuminuria in Hyperglycemic Critically Ill Patients Treated with Insulin or Metformin
por: Panahi, Yunes, et al.
Publicado: (2011) -
Prevalence of candidemia and associated candida subtypes following severe sepsis in non-neutropenic critically ill patients
por: Kashiha, Arefeh, et al.
Publicado: (2018) -
Vesicourethral Reflux in Pediatrics With Hypermobility Syndrome
por: Beiraghdar, Fatemeh, et al.
Publicado: (2013) -
Efficacy and Safety of Immunotherapy with Interferon-Gamma in the Management of Chronic Sulfur Mustard-Induced Cutaneous Complications: Comparison with Topical Betamethasone 1%
por: Panahi, Yunes, et al.
Publicado: (2012) -
Comparison of Piascledine (Avocado and Soybean Oil) and Hormone Replacement Therapy in Menopausal-Induced Hot Flashing
por: Panahi, Yunes, et al.
Publicado: (2011)